Is this you? Create Your Porfile
Avatar

Luis Anglada

Grupo México

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Luis Anglada is active.

Explore More

Publication

Featured researches published by Luis Anglada.

European Journal of Medicinal Chemistry | 1988

Inhibitors of gastric acid secretion: N-sulphonyl formamidines in a series of new histamine H2-receptor antagonists

Luis Anglada; Márquez M; Aurelio Sacristan; Ortiz Ja

Abstract A series of 19 new N -sulphonyl formamidines have been synthesized and evaluated as inhibitors of gastric acid secretion. Compounds 4a and 4n were the most active and were selected for further pharmacological and toxicological studies.

Journal of Heterocyclic Chemistry | 1992

The synthesis and biological activity of new 7‐[2‐(cyanomethyl)piperazinyl]‐ and 7‐[3‐(cyanomethyl)piperazinyl]quinolone antibacterials

Santiago Gubert; C. Braojos; Luis Anglada; Jordi Bolos; Celia Palacin

Journal of Organic Chemistry | 1992

Asymmetric synthesis of pyrrolo[1,2-b][1,2]diazepine derivatives as potential antihypertensive drugs

Jordi Bolos; Ángel Pérez; Santiago Gubert; Luis Anglada; Aurelio Sacristan; Jose A. Ortiz

Journal of Heterocyclic Chemistry | 1993

Synthesis of perhydropyrazino[1,2-d][1,4]diazepine, a new heterocyclic compound

Santiago Gubert; C. Braojos; Luis Anglada; Jordi Bolos; Aurelio Sacristan; Ortiz Ja

Archive | 2007

PYRAZOLO[1,5-A]PYRIMIDINES, PROCESSES, USES AND COMPOSITIONS

Luis Anglada; Albert Palomer; Antonio Guglietta

Archive | 1989

Sulfonamidines, a process for preparing them and pharmaceutical compositions containing them

Rafael Foguet; Luis Anglada; Josep M. Castello; Aurelio Sacristan; Jose A. Ortiz

Archive | 2008

Amorphous form of an anti-inflammatory compound

Luis Anglada; Carlos Albet; Antonio Guglietta

Archive | 2007

Amorphous form of n-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo [1,5-a]pyrimidin-7-yl]-phenyl-n-methyl-acetamide

Luis Anglada; Albert Palomer; Antonio Guglietta

Archive | 2006

N-(3-(imidazo [1,5-a]pyrimidin-4-yl)phenyl]-sulfonamides and n-[3-(imidazo[1,5-a]pyrimidin-4-yl)-phenyl]-carboxamides and their use as gabaa receptor modulators

Luis Anglada; Albert Palomer; Antonio Guglietta

Drug Research | 1997

Synthesis and assessment of formamidines as new histamine H2-receptor antagonists.

Luis Anglada; Manuel Raga; Márquez M; Aurelio Sacristan; Josep M. Castello; Ortiz Ja

Explore More

Collaboration

Dive into the Luis Anglada's collaboration.

Top Co-Authors
Avatar

Albert Palomer

University of Barcelona

View shared research outputs
Top Co-Authors
Avatar

Antonio Guglietta

Grupo México

View shared research outputs
Top Co-Authors
Avatar

Aurelio Sacristan

Grupo México

View shared research outputs
Top Co-Authors
Avatar

Rafael Foguet

Instituto de Salud Carlos III

View shared research outputs
Top Co-Authors
Avatar

Jose A. Ortiz

Grupo México

View shared research outputs
Top Co-Authors
Avatar

Celia Palacin

Grupo México

View shared research outputs
Top Co-Authors
Avatar

Jordi Bolos

Grupo México

View shared research outputs
Top Co-Authors
Avatar

Josep M. Castello

Grupo México

View shared research outputs
Top Co-Authors
Avatar

Manuel Raga

Grupo México

View shared research outputs
Top Co-Authors
Avatar

Ortiz Ja

Grupo México

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge